Financhill
Back

Aritzia Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
100

ATZAF
Aritzia

Last Price:
$46.20
Seasonality Move:
-1.14%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$126.86
Seasonality Move:
2.9%
Buy
100
Aritzia (ATZAF) is a Buy

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $46.20. The Score for ATZAF is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • ATZAF is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.89. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $46.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATZAF is experiencing slight buying pressure.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.61 Buy
Relative Strength Index (14 RSI): 73.84 Buy
Chaikin Money Flow: 641 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.64 - 41.38) Buy
Bollinger Bands (100): (31.71 - 37.93) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.34 Buy
Relative Strength Index (14 RSI): 87.18 Buy
Chaikin Money Flow: -9953478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.29 - 99.79) Buy
Bollinger Bands (100): (72.19 - 89.87) Buy

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.93 Buy
20-day SMA: 38.68 Buy
50-day SMA: 35.27 Buy
200-day SMA: 31.38 Buy
8-day EMA: 42.63 Buy
20-day EMA: 39.59 Buy
50-day EMA: 36.71 Buy
200-day EMA: 32.15 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.56 Buy
20-day SMA: 89.05 Buy
50-day SMA: 87.32 Buy
200-day SMA: 76.32 Buy
8-day EMA: 102.15 Buy
20-day EMA: 92.65 Buy
50-day EMA: 87.08 Buy
200-day EMA: 77.64 Buy

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.61 per share, and an increase next year of $0.56 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):